590 related articles for article (PubMed ID: 15811164)
1. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
3. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
4. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
5. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
Cherif A; Jabnoun S; Khrouf N
Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
7. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus.
Van Overmeire B
Int J Clin Pract Suppl; 2003 Apr; (135):23-7. PubMed ID: 12723743
[TBL] [Abstract][Full Text] [Related]
8. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
9. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants.
Richards J; Johnson A; Fox G; Campbell M
Pediatrics; 2009 Aug; 124(2):e287-93. PubMed ID: 19651568
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants.
Barzilay B; Youngster I; Batash D; Keidar R; Baram S; Goldman M; Berkovitch M; Heyman E
Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F116-9. PubMed ID: 21840880
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants.
Lago P; Salvadori S; Opocher F; Ricato S; Chiandetti L; Frigo AC
Neonatology; 2014; 105(1):46-54. PubMed ID: 24281435
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
[TBL] [Abstract][Full Text] [Related]
14. High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study.
Dani C; Vangi V; Bertini G; Pratesi S; Lori I; Favelli F; Ciuti R; Bandinelli A; Martano C; Murru P; Messner H; Schena F; Mosca F
Clin Pharmacol Ther; 2012 Apr; 91(4):590-6. PubMed ID: 22089267
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
[TBL] [Abstract][Full Text] [Related]
16. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
[TBL] [Abstract][Full Text] [Related]
17. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.
Erdeve O; Yurttutan S; Altug N; Ozdemir R; Gokmen T; Dilmen U; Oguz SS; Uras N
Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F279-83. PubMed ID: 22147286
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus.
Fanos V; Benini D; Verlato G; Errico G; Cuzzolin L
Fundam Clin Pharmacol; 2005 Apr; 19(2):187-93. PubMed ID: 15810899
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oral and intravenous Ibuprofen for medical closure of patent ductus arteriosus: which one is better?
Olukman O; Calkavur S; Ercan G; Atlihan F; Oner T; Tavli V; Kultursay N
Congenit Heart Dis; 2012; 7(6):534-43. PubMed ID: 22613269
[TBL] [Abstract][Full Text] [Related]
20. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
